This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Awwad, R. A. Articles by Howell, G. M. Search for Related Content PubMed PubMed Citation Articles by Awwad, R. A. Articles by Howell, G. M.

The Role of Transforming Growth Factor in Determining Growth Factor Independence¹

Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263 [L. E. H., M. G. B., G. M. H.]; Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43614-5804 [R. A. A., R. F.]; Departments of Surgery and Biochemistry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7840 [H. Y., N. S.]; Department of Stomatology, University of California at San Francisco, San Francisco, California 94143 [B. Z.]; Ireland Cancer Center and Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 [J. K. V. W., E. Z.]; and University of Texas Medical Branch, Route 0542, 301 University Boulevard, Galveston, Texas 77555 [T. C. K.]

Growth factor independence is a hallmark of malignancy that is attributed to the development of autocrine growth factor loops in cancer cells. However, growth factor-dependent normal cells also exhibit autocrine activity, thus raising the issue of how endogenously produced activity in cancer cells differs in a manner that leads to growth factor independence. We have examined this issue by comparing growth factor-independent HCT116 human colon carcinoma cells with a growth factor-dependent subcompartment of malignant cells designated HCT116b that was isolated from the same patient tumor. Therefore, the development of the growth factor-independent phenotype represents clonal progression within the tumor in vivo. The growth factor independence of HCT116 cells was shown to be dependent on autocrine transforming growth factor (TGF)- activity, yet the isoparental HCT116b subcompartment showed similar levels of TGF- expression as HCT116 when cells were in exponential growth. When both cell lines were growth arrested by nutrient deprivation, HCT116b cells required nutrient replenishment and growth factors for reinitiation of DNA synthesis, whereas HCT116 cells required only nutrient replenishment. In contrast to growth factor-dependent HCT116b cells, the HCT116 cells showed up-regulation of TGF- expression during growth arrest as a result of enhanced transcription. This increased TGF- expression in quiescent HCT116 cells was associated with constitutive epidermal growth factor receptor (EGFR) activation in the growth-arrested state, whereas growth-arrested HCT116b cells did not show EGFR activation. TGF- antisense transfection of HCT116 cells showed that EGFR activation was due to increased TGF- expression. Pretreatment of growth-arrested HCT116 cells with AG1478, a selective inhibitor of EGFR tyrosine kinase activity, blocked the reinitiation of DNA synthesis, demonstrating that growth factor independence was due to the increased TGF- expression and EGFR activation of these cells in growth arrest relative to growth factor-dependent HCT116b cells. Importantly, the level of EGFR activation in growth-arrested HCT116 cells was only slightly higher than that of exponential cells, indicating that it was inappropriate EGFR activation in growth arrest rather than the amplitude of activation that generated growth factor independence.

This article has been cited by other articles:

				C. R. Daniel, R. M. Bostick, W. D. Flanders, Q. Long, V. Fedirko, E. Sidelnikov, and M. E. Seabrook TGF-{alpha} Expression as a Potential Biomarker of Risk Within the Normal-appearing Colorectal Mucosa of Patients with and without Incident Sporadic Adenoma Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 65 - 73. [Abstract] [Full Text] [PDF]

				A. Rajput, A. P. Koterba, J. I. Kreisberg, J. M. Foster, J. K.V. Willson, and M. G. Brattain A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo Cancer Res., January 15, 2007; 67(2): 665 - 673. [Abstract] [Full Text] [PDF]

				Y. Zhou, S. Li, Y. P. Hu, J. Wang, J. Hauser, A. N. Conway, M. A. Vinci, L. Humphrey, E. Zborowska, J. K.V. Willson, et al. Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis Cancer Res., January 1, 2006; 66(1): 404 - 411. [Abstract] [Full Text] [PDF]